Cara Therapeutics (CARA)
$19.37 0.59 (2.96%)
17:35 EDT CARA Stock Quote Delayed 15 Minutes
Previous Close $19.37
Market Cap 656.15M
PE Ratio -12.42
Volume (Avg. Vol.) 402,200
Day's Range 19.35 - 20.13
52-Week Range 12.19 - 24.30
Dividend & Yield N/A (N/A)
CARA Stock Predictions, Articles, and Cara Therapeutics News
- From InvestorPlace
- From the Web
It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.
Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Putting in the work may pay off big for In 2018, setting up the clinical studies dominated Cara Therapeutics' activities. For 2019, the study results may drive Cara stock higher. stock
CARA stock could be meaningfully boosted by drug development updates in 2019
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.
Cara Therapeutics (CARA) shares were up more than 11% on Wednesday as the company received good news regarding its latest clinical trial.
3 Stocks to Watch on Wednesday: Square Inc (SQ), Cara Therapeutics Inc (CARA) and Healthcare Services Group, Inc. (HCSG)
Square (SQ) continues its breathtaking 2017 rally Wednesday, Cara Therapeutics (CARA) jumps on trial results and Healthcare Services Group (HCSG) scores a post-earnings bump.
Why Best Buy Co Inc (BBY), Abercrombie & Fitch Co. (ANF) and Cara Therapeutics Inc (CARA) Are 3 of Today’s Worst Stocks
Too bad for Cara Therapeutics (CARA), Abercrombie & Fitch (ANF) and Best Buy (BBY) owners -- the market doesn't do do-overs.
Why Pandora Media Inc (P), Cara Therapeutics Inc (CARA) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks
Micron Technology (MU), Pandora (P) and Cara Therapeutics (CARA) all ended the trading week on a bearish foot, but for understandable reasons.
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Cara Therapeutics (CARA) stock was flying high on Friday following good news from the U.S. Food and Drug Administration.
Why Sears Holdings Corp (SHLD), Cara Therapeutics Inc (CARA) and Exxon Mobil Corporation (XOM) Are 3 of Today’s Worst Stocks
Cara Therapeutics (CARA), Sears Holdings (SHLD) and Exxon Mobil (XOM) and the day and the week on a low note, though for understandable reasons.
From Market News Video
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cara Therapeutics Inc (CARA), where a total volume of 4,755 contracts has been traded thus far today, a contract volume which is representative of approximately 475,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 44.8% of CARA's average daily trading volume over the past month, of 1.1 million shares..
From The Street
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!